Quick Takeaways
- Deep Track Capital, LP filed SCHEDULE 13G for X4 Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (XFOR).
- Disclosed ownership: 10%.
- Date of event: 12 Aug 2025.
Deep Track Capital, LP - 12 Aug 2025 SCHEDULE 13G Report for X4 Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (XFOR)
- Filing Manager
- Deep Track Capital, LP
- Reporting Manager
- Deep Track Capital, LP
- Symbol
- XFOR
- Shares outstanding
- 23,693,644 shares
- Disclosed Ownership
- 2,366,995 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G
- Filing time
- 19 Aug 2025, 16:05:10 UTC
- Date of event
- 12 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Deep Track Capital, LP disclosed 10% ownership in X4 Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (XFOR) on 12 Aug 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 19 Aug 2025, 16:05.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Deep Track Capital, LP | 10% | 2,366,995 | 0 | 2,366,995 | /s/ David Kroin | David Kroin, Managing Member of the General Partner of the Investment Adviser | |
| Deep Track Biotechnology Master Fund, Ltd. | 10% | 2,366,995 | 0 | 2,366,995 | /s/ David Kroin | David Kroin, Director | |
| David Kroin | 10% | 2,366,995 | 0 | 2,366,995 | /s/ David Kroin | David Kroin |